Koyfin Home > Directory > Health Care > Aduro Biotech > Cash from Investing Activities

Aduro Biotech Cash from Investing Activities Chart (ADRO)

Aduro Biotech annual/quarterly Cash from Investing Activities from 2013 to 2020.
  • Aduro Biotech Cash from Investing Activities for the quarter ending June 06, 2020 was $-3m a -275.34% increase of 7m year over year
  • Aduro Biotech Cash from Investing Activities for the last 12 months ending June 06, 2020 was $58m a 140.32% increase of 81m year over year
  • Aduro Biotech Annual Cash from Investing Activities for 2019 was $-2m a 2,335.22% decrease of -41m from 2018
  • Aduro Biotech Annual Cash from Investing Activities for 2018 was $39m a -125.70% decrease of -50m from 2017
  • Aduro Biotech Annual Cash from Investing Activities for 2017 was $89m a 136.05% increase of 121m from 2016
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Cash from Investing Activities Data

06/2020$-3m
03/2020$43m
12/2019$28m
09/2019$-10m
06/2019$-18m
03/2019$-2m
12/2018$6m
09/2018$33m
06/2018$38m
03/2018$-38m

Annual ADRO Cash from Investing Activities Data

2019$-2m
2018$39m
2017$89m
2016$-32m
2015$-298m
2014$-1m
2013$0m
2012$0m